Mangoceuticals jumped 23% premarket after launching programs that give customers direct access to Eli Lilly Zepbound and Novo Nordisk Wegovy. The new MangoRx Direct and PeachesRx Direct programs will supply the drugs through LillyDirect and NovoCare pharmacies, expanding access to popular obesity treatments.